Mercer Global Advisors
GRCL

Mercer Global Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Mercer Global Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,500
Closed -$24K – 2076
2022
Q4 		$24K Buy
+10,500
New +$32.2K ﹤0.01% 1901

Other funds holding GRCL

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Mercer Global Advisors's GRCL Position: Q1 2023 in Review

Mercer Global Advisors sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2023, closing a stake of 10,500 shares — an estimated $24K sold.

Mercer Global Advisors first reported a position in GRCL in Q4 2022 and held it in 1 quarter. The position peaked at $24K in Q4 2022. 33 funds tracked by Wall St. Rank hold GRCL as of Q1 2023.

  • Mercer Global Advisors reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Mercer Global Advisors sold 10,500 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2023, an estimated $24K.
  • Mercer Global Advisors first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2022 and held it in 1 quarter.
  • Mercer Global Advisors's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $24K in Q4 2022.
  • 33 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2023.

Based on Mercer Global Advisors's 13F filing for Q1 2023, filed 16 May 2023.